NCT04927793View on ClinicalTrials.gov

Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 28, 2021

Primary Completion Date

July 4, 2021

Study Completion Date

July 4, 2021

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
DRUG

EDP-938

\[14C\]EDP-938

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT04927793 - Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter